Indianapolis, INDIANA14 Active Studies

Essential Tremor Clinical Trials in Indianapolis, INDIANA

Find 14 actively recruiting essential tremor clinical trials in Indianapolis, INDIANA. Connect with local research sites and explore new treatment options.

14
Active Trials
11
Sponsors
3,665
Enrolling

Recruiting Essential Tremor Studies in Indianapolis

RecruitingIndianapolis, INDIANANCT06914895

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 week...

905 participants
Eli Lilly and Company
View Study Details
RecruitingIndianapolis, INDIANANCT07044336

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to physician's choice of chemotherapy (doxorubicin or p...

700 participants
AstraZeneca
View Study Details
RecruitingIndianapolis, INDIANANCT05844982

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 Mg) Intravitreal Implants Vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following ...

600 participants
Jaeb Center for Health Research
View Study Details
RecruitingIndianapolis, INDIANANCT06233799

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing...

360 participants
National Institute on Drug Abuse (NIDA)
View Study Details
RecruitingIndianapolis, INDIANANCT05797831

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The ...

268 participants
Kartos Therapeutics, Inc.
View Study Details
RecruitingIndianapolis, INDIANANCT05166161

A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria

The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein cons...

200 participants
PTC Therapeutics
View Study Details
RecruitingIndianapolis, INDIANANCT05762107

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hy...

186 participants
Zucara Therapeutics Inc.
View Study Details
RecruitingIndianapolis, INDIANANCT06449677

Bionic Pancreas in CFRD

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using...

150 participants
Jaeb Center for Health Research
View Study Details
RecruitingIndianapolis, INDIANANCT04634578

Bevacizumab Treatment For Type 1 ROP

Type 1 retinopathy of prematurity in zone I represents the most severe type of ROP and has the worst prognosis. It is unknown whether low-dose bevacizumab will be successful in these severe cases. Als...

80 participants
Jaeb Center for Health Research
View Study Details
RecruitingIndianapolis, INDIANANCT05594563

TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answer are: * Does it reduce stress on the cells that make insu...

70 participants
Emily K. Sims
View Study Details
RecruitingIndianapolis, INDIANANCT05154487

A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

This is a 2 stage multi-center study designed to evaluate the efficacy of the combination of alpelisib and fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by e...

51 participants
GOG Foundation
View Study Details
RecruitingIndianapolis, INDIANANCT06524960

Denosumab for Type 1 Diabetes

Type 1 diabetes (T1D) arises from abnormal immune cell-mediated injury to beta cells that make insulin. The injured beta cells can then no longer make the needed amount of insulin to stay healthy. How...

45 participants
City of Hope Medical Center
View Study Details
RecruitingIndianapolis, INDIANANCT05521438

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

This study has been designed to determine the safety, tolerability and efficacy of QRX003 lotion 2%, 4% QAM or 4% BID in subjects with Netherton Syndrome (NS) in comparison to vehicle...

30 participants
Quoin Pharmaceuticals
View Study Details
RecruitingIndianapolis, INDIANANCT05789056

Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome

To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome...

20 participants
Quoin Pharmaceuticals
View Study Details

About Essential Tremor Clinical Trials in Indianapolis

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 14 essential tremor clinical trials recruiting participants in Indianapolis, INDIANA. These studies are seeking a combined 3,665 participants. Research is being sponsored by Eli Lilly and Company, AstraZeneca, Jaeb Center for Health Research and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Indianapolis — FAQ

Are there essential tremor clinical trials in Indianapolis?

Yes, there are 14 essential tremor clinical trials currently recruiting in Indianapolis, INDIANA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 14 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated March 2, 2026 from ClinicalTrials.gov